OBJECTIVES: As a result of this activity, the participant should be able to:
1. Develop an understanding of evidence-based recommendations for psychotropic medication in pregnancy and lactation.
2.Describe the current FDA classification of prescription drug labelling for perinatal patients.
3. Utilize clinical resources when having discussions with patients about risks, benefits, and alternatives to psychiatric medications in the perinatal period. 

FACULTY DISCLOSURE: Miranda Morgan, D.O. has no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNERS DISCLOSURE:  Louis A. Gamino, PhD, ABPP, FT and James Bourgeois, O.D., M.D. have no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Meeting Invitation link

https://bswhealth.webex.com/bswhealth/j.php?MTID=m4f7971cc85cb31e53ac470be4a582c5c